Treating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians never know when, where and what resistance might emerge, leaving them one step behind.
AstraZeneca mulls risk strategy for Ultomiris following FDA response letter – Pharmaceutical Technology
The therapy is approved for NMOSD in multiple regions, including the European Union (EU) and Japan. Image Credit: Roland Magnusson / Shutterstock. The US Food